Application Note

The Journey To AAV Production In Suspension – Scaling-Up Your Process

Source: Sartorius

By Sandra Klausing, Sartorius Xell GmbH

Adeno-associated viruses AAV GettyImages-1322096218

Adeno-associated viral vectors (AAVs) are among the most widely used vectors for gene therapy applications. A robust AAV manufacturing process relies on productive host cells, and typically HEK293 cells are the cell line of choice.

HEK293 cells are traditionally grown in adherent, monolayer cultures. Transitioning cells to suspension culture is the first step in the journey towards a scalable AAV production process.

In this application note, we demonstrate the performance of our easy protocol for the production of two AAV serotypes. We applied this procedure to an initial scale-up step from shake flasks to 2 L benchtop bioreactors, and measured both cell viability and AAV titer.

access the Application Note!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online